Literature DB >> 15057409

Validation of cell culture models for the intestine and the blood-brain barrier and comparison of drug permeation.

Udo Bock1, Thomas Flötotto, Eleonore Haltner.   

Abstract

Cell culture models are useful tools to study the uptake of drugs across the barriers of the human body, like the intestine, the skin or the blood-brain barrier. Cell-based in vitro models not only help to reduce the number of animals used but are also much faster to perform, more cost effective and give more reproducible data than animal studies. Given the increasing number of new drugs and chemicals under development, there is an urgent need for the establishment of such in vitro models. However, the validity of such in vitro models is reflected by its ability to accurately predict the behaviour of a substance at the corresponding in vivo barrier. Here, we compare a well-established cell culture model for the intestine, based on Caco-2 colon carcinoma cells, with a primary cell culture model of the blood-brain barrier. We find that Caco-2 cells and cells of the blood-brain barrier have different barrier properties. Therefore, cells used for cell-based assays should be derived from the corresponding tissue to reflect the in vivo barrier characteristics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057409

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  5 in total

Review 1.  Application of method suitability for drug permeability classification.

Authors:  Donna A Volpe
Journal:  AAPS J       Date:  2010-09-02       Impact factor: 4.009

2.  Human barrier models for the in vitro assessment of drug delivery.

Authors:  Matthias Schweinlin; Angela Rossi; Nina Lodes; Christian Lotz; Stephan Hackenberg; Maria Steinke; Heike Walles; Florian Groeber
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

3.  Human Primary Cell-Based Organotypic Microtissues for Modeling Small Intestinal Drug Absorption.

Authors:  Seyoum Ayehunie; Tim Landry; Zachary Stevens; Alex Armento; Patrick Hayden; Mitchell Klausner
Journal:  Pharm Res       Date:  2018-02-23       Impact factor: 4.200

4.  Biopharmaceutical characterization of the telomerase inhibitor BRACO19.

Authors:  S Taetz; C Baldes; T E Mürdter; E Kleideiter; K Piotrowska; U Bock; E Haltner-Ukomadu; J Mueller; H Huwer; U F Schaefer; U Klotz; C-M Lehr
Journal:  Pharm Res       Date:  2006-05-04       Impact factor: 4.580

5.  Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments.

Authors:  Aroha B Sánchez; Ana C Calpena; Mireia Mallandrich; Beatriz Clares
Journal:  Pharmaceutics       Date:  2019-11-29       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.